vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $39.6M, roughly 1.9× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 8.7%, a 27.2% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs -10.9%). Over the past eight quarters, SAUL CENTERS, INC.'s revenue compounded faster (6.2% CAGR vs -15.0%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
BFS vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $39.6M |
| Net Profit | $6.5M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 65.4% | 32.5% |
| Net Margin | 8.7% | 35.9% |
| Revenue YoY | 10.6% | -10.9% |
| Net Profit YoY | -19.6% | 117.2% |
| EPS (diluted) | $0.15 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $39.6M | ||
| Q3 25 | $72.0M | $43.4M | ||
| Q2 25 | $70.8M | $43.4M | ||
| Q1 25 | $71.9M | $47.3M | ||
| Q4 24 | $67.9M | $44.4M | ||
| Q3 24 | $67.3M | $53.1M | ||
| Q2 24 | $66.9M | $53.1M | ||
| Q1 24 | $66.7M | $54.8M |
| Q4 25 | $6.5M | $14.2M | ||
| Q3 25 | $10.5M | $12.8M | ||
| Q2 25 | $10.7M | $2.5M | ||
| Q1 25 | $9.8M | $21.5M | ||
| Q4 24 | $8.1M | $6.5M | ||
| Q3 24 | $14.5M | $2.8M | ||
| Q2 24 | $14.4M | $18.5M | ||
| Q1 24 | $13.6M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | 73.6% | 81.5% | ||
| Q2 24 | 74.2% | 74.2% | ||
| Q1 24 | 72.8% | 72.1% |
| Q4 25 | 65.4% | 32.5% | ||
| Q3 25 | 69.1% | 36.6% | ||
| Q2 25 | 68.7% | 33.6% | ||
| Q1 25 | 66.5% | 51.1% | ||
| Q4 24 | 82.9% | 10.6% | ||
| Q3 24 | 72.8% | 26.1% | ||
| Q2 24 | 75.0% | 51.4% | ||
| Q1 24 | 72.4% | 44.6% |
| Q4 25 | 8.7% | 35.9% | ||
| Q3 25 | 14.6% | 29.6% | ||
| Q2 25 | 15.1% | 5.7% | ||
| Q1 25 | 13.6% | 45.4% | ||
| Q4 24 | 11.9% | 14.7% | ||
| Q3 24 | 21.5% | 5.3% | ||
| Q2 24 | 21.6% | 34.8% | ||
| Q1 24 | 20.4% | 34.2% |
| Q4 25 | $0.15 | $0.15 | ||
| Q3 25 | $0.32 | $0.12 | ||
| Q2 25 | $0.33 | $0.02 | ||
| Q1 25 | $0.29 | $0.21 | ||
| Q4 24 | $0.22 | $0.05 | ||
| Q3 24 | $0.48 | $0.03 | ||
| Q2 24 | $0.48 | $0.20 | ||
| Q1 24 | $0.45 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $164.1M |
| Total DebtLower is stronger | $468.4M | $42.8M |
| Stockholders' EquityBook value | $307.8M | $248.3M |
| Total Assets | $2.2B | $380.4M |
| Debt / EquityLower = less leverage | 1.52× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $164.1M | ||
| Q3 25 | $11.8M | $127.4M | ||
| Q2 25 | $5.3M | $152.7M | ||
| Q1 25 | $6.5M | $132.1M | ||
| Q4 24 | $10.3M | $125.0M | ||
| Q3 24 | $7.2M | $137.4M | ||
| Q2 24 | $6.9M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | $468.4M | $42.8M | ||
| Q3 25 | $1.6B | $21.1M | ||
| Q2 25 | $1.6B | $7.1M | ||
| Q1 25 | $1.5B | $6.9M | ||
| Q4 24 | $455.8M | $6.6M | ||
| Q3 24 | $1.5B | $823.2K | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $307.8M | $248.3M | ||
| Q3 25 | $316.6M | $248.0M | ||
| Q2 25 | $322.4M | $244.6M | ||
| Q1 25 | $328.4M | $226.4M | ||
| Q4 24 | $335.8M | $195.1M | ||
| Q3 24 | $341.8M | $205.0M | ||
| Q2 24 | $345.7M | $8.8M | ||
| Q1 24 | $347.1M | $9.0M |
| Q4 25 | $2.2B | $380.4M | ||
| Q3 25 | $2.2B | $321.4M | ||
| Q2 25 | $2.1B | $315.3M | ||
| Q1 25 | $2.1B | $284.6M | ||
| Q4 24 | $2.1B | $266.1M | ||
| Q3 24 | $2.1B | $296.5M | ||
| Q2 24 | $2.1B | $19.5M | ||
| Q1 24 | $2.0B | $19.8M |
| Q4 25 | 1.52× | 0.17× | ||
| Q3 25 | 5.02× | 0.09× | ||
| Q2 25 | 4.85× | 0.03× | ||
| Q1 25 | 4.70× | 0.03× | ||
| Q4 24 | 1.36× | 0.03× | ||
| Q3 24 | 4.37× | 0.00× | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 15.35× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $52.0M | ||
| Q3 25 | $20.6M | $-20.9M | ||
| Q2 25 | $26.6M | $-8.3M | ||
| Q1 25 | $30.4M | $1.9M | ||
| Q4 24 | $121.2M | $-7.3M | ||
| Q3 24 | $26.5M | $5.0M | ||
| Q2 24 | $32.1M | $19.2M | ||
| Q1 24 | $33.8M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | $-28.3M | $4.6M | ||
| Q2 24 | $-12.5M | $18.3M | ||
| Q1 24 | $-11.7M | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | -42.1% | 8.7% | ||
| Q2 24 | -18.7% | 34.5% | ||
| Q1 24 | -17.6% | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | 81.5% | 0.8% | ||
| Q2 24 | 66.7% | 1.6% | ||
| Q1 24 | 68.3% | 1.3% |
| Q4 25 | 15.35× | 3.66× | ||
| Q3 25 | 1.97× | -1.63× | ||
| Q2 25 | 2.48× | -3.39× | ||
| Q1 25 | 3.10× | 0.09× | ||
| Q4 24 | 14.98× | -1.12× | ||
| Q3 24 | 1.83× | 1.77× | ||
| Q2 24 | 2.22× | 1.04× | ||
| Q1 24 | 2.48× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFS
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
